News|Articles|February 4, 2025

FDA Updates in Urology: January 2025

A recap of the FDA submissions and regulatory decisions in urology from January 2025.

Welcome to Urology Times’ monthly US Food and Drug Administration (FDA) update! This month, key developments include advances in prostate cancer treatment, a new approach to bladder cancer therapy, and expanded indications for emerging urologic drugs. Plus, a novel testosterone assay is set to impact diagnostic testing.